Constellation Pharmaceuticals

December 12, 2019

Ash 2019 winners and losers

Data and M&A lifts buoyant biopharma companies from Fate Therapeutics to Rocket, though on share price gain Forty Seven wins Ash 2019.

November 07, 2019

Ash 2019 preview – the first winner and losers emerge

Celgene’s registrational Transcend NHL-001 study will be a big story at Ash, but the early focus falls on what has not been presented.

November 04, 2019

Share price movers – October 2019

July 09, 2018

The venture money keeps flowing for biopharma

Private drug developers raised a record $8.5bn in the first half of 2018, amid a surge in mega rounds.

April 24, 2018

Accelerated filing delay could be the least of Epizyme’s problems

January 12, 2016

Deal flurry comes just in time for JP Morgan

May 07, 2015

Gilead deal shows desire to put oncology at centre of post-Hep C strategy

December 19, 2014

Merck & Co gives epigenetics a boost

October 07, 2011

Early success with novel leukaemia drug points to epigenetic progress